Mount Hope Mining is preparing for a 9 December ASX listing, focusing on copper and gold exploration in the Cobar Basin, with five high-priority targets and a strategy based on recent geological insights.
Copyright 2024 – Finance News Network
Source: Finance News Network
03 Apr 2023 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses the company's JV with TAQAT to produce anode materials for electric vehicles.
Read More03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canadian cannabis market and what’s planned for the portfolio.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More03 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
Read More09 Jun 2022 - Novatti Group Limited (ASX:NOV) CEO and Managing Director Peter Cook discusses Novatti's recent deals with Ripple and Stellar.
Read More01 Mar 2021 - RooLife Group Limited (ASX:RLG) CEO Bryan Carr talks about taking global brands into the Chinese market, targeting consumers directly via a range of platforms and e-commerce solutions.
Read More18 Oct 2019 - Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, talks about the company's strategy, recent capital raising, and results from the drill program at its Montney project.
Read More16 Aug 2023 - Mark Leong - Executive Chairman - Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Read More21 Mar 2023 - Centuria Capital Group Limited (ASX:CNI) Joint CEO John McBain discusses the rising interest rate environment, the company's expansion into the healthcare and agricultural sectors, the acquisition of Primewest, and possible future M&A opportunities.
Read More09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.
Read More
